Facebook Twitter LinkedIn Google Plus RSS

BD gets approval for generic injectable drugs

By ,

Franklin Lakes-based medical technology company BD announced today the U.S. Food and Drug Administration has approved its first drug to be offered in the just-launched BD Simplist line of prefilled generic injectables.

According to BD, Simplist products will be commercialized and manufactured by BD Rx Inc., a wholly owned subsidiary of the company. The first product BD Rx will launch is an injectable antihistamine.

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!